Trial Profile

A Phase 1 Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 28 Sep 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pegloprastide (Primary)
Indications Advanced breast cancer; Ductal carcinoma; Early breast cancer
Focus Adverse reactions; First in man
Sponsors Avelas BioSciences

Most Recent Events

26 Sep 2017 Results published in Annals of Surgical Oncology, according to an Avelas BioSciences media release.
08 Dec 2016 Results published in an Avelas BioSciences media release.
08 Dec 2016 According to an Avelas BioSciences media release, data from the study has been presented at the San Antonio Breast Cancer Symposium.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com